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Phytosome is a complex of a natural active ingredient and phospholipids. The term ‘Phyto’ means plant while 
‘some’ means cell like structure. It is claimed that phytosome increases absorption of "conventional herbal 
extracts" or isolated active principles both orally as well as topically. In this era phytosome gain popularity as 
a potential drug delivery device due to excessive demand and utility of herbs or herb based medicines. This 
advance technology offers amenities like improved absorption, enhanced delivery & increased bioavailability 
of herbal extracts. These drug-phospholipid complexes can be fabricated in the form of solution, suspension, 
emulsion, syrup, lotion, gel, cream, aqueous micro dispersions. Standardized plant extracts, mainly polar 
phytoconstituents like flavonoids, terpenoids, tannins, xanthones shall be introduced in form of phytosome. 
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INTRODUCTION 
Herbs are serving as sources of potent medicine form 
the ancient time. In the recent era it has been found that 
use of some phyto medicines are increasing due to its 
efficacy and comparative low toxicity profile as well 
less side effect as compare to conventional synthetic 
medicines.The World Health Organization (WHO) 
estimates that 80 percent of the population of some 
Asian and African countries presently use phyto 
medicine for some aspect of primary health care. 
Studies in the United States and Europe have shown 
that use of phyto medicine increasing in recent years as 
scientific evidence about the effectiveness of herbal 
medicine has become more widely available.2,3 
The clinically and pharmacologically tested bioactive 
group of compounds like alkaloids, flavonoids, 
polyphenolic components randomly used for effective 
management of different ill health condition either in 
crud form or in the form of formulations. It is fact that 
development of phyto formulation is tedious due to the 
solubility and compatibility issue of active constitutes 
with other formulation variables4. Many 
pharmacologically active phytochemicals or herbal 
extracts exhibits poor in-vivo response despite of the 
extraordinary potential in-vitro results due to 
unpredictable physiochemical behaviour of active 
constitutes, ultimately resulting in poor absorption and 
poor bioavailability5. The bioavailability can be 
improved with the use of different novel delivery 
systems like liposomes, niosomes and phytosomes 
which can enhance the rate of release as well as the 
capacity to cross the lipidal biomembranes. Among the 
vesicular systems phytosome shows comparatively 
better acceptance and potency.  
Phytosomes are advanced delivery system most 
popularly use to deliver phyto constituents or herbal 
product in vesicular encapsulated form. It is mainly 
developed by binding individual component of herbal 
extract to phosphatidylcholine resulting a product that 
is better absorbed and produces better results than the 
conventional one. The major component of this 
delivery system is phospholipid’s molecular5. They are 
shows unique structural arrangement includes a polar 
head & two non polar tails that provide a facility of 
dual solubility. The phospholipid acts as an effective 
emulsifier, also having easy access through the 
biomembrane. There are many phytoconstitutes that are 
successfully incorporated into phytosome including 
Ginkgo Biloba, Grape seed Hawthorn, Milk thistle, 
Green tea & Ginsengs. This review shall provide detail 
information regarding the concept of phytosome and its 
various prospects as delivery system. 
 
Advantage of Phytosome: 1, 6-8 
 It enhances the absorption of lipid insoluble polar 
phytoconstituent through oral as well as topical 
route showing better bioavailability. 
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 This technology offers a stable and cost effective 
delivery of phytoconstituent. Due to improve 
absorption capabilities it shows better efficacy in 
comparatively low dose. 
 The phosphatidylcholine used in preparation of 
phytosome besides acting as a carrier it also act as 
a hepatoprotective agent hence produce synergistic 
effect for hepatoprotective substances  
 The vesicular structure of phytosome helps to 
protect valuable component of herbal extracts from 
destruction by digestive secretions & gut bacteria. 
 Phytosome can be used for systemic targeting. It is 
widely used in cosmetic technology due to its 
more skin penetration ability & high lipid 
permeability. 
 
 
Fig I Comparison between transverse Section of 
Liposome and Phytosome 
 
Properties of Phytosome
9
: 
(1) The term phytosome is used to define a complex 
between a natural product & phospholipids, like 
soy lipid that are obtained by the reaction of 
stoichiometric amounts of phospholipids and 
phytoconstituent in an appropriate solvent. 
Spectroscopic data reveals that the interaction 
phospholipids substrate is due to the formation of 
hydrogen bonds between the polar head of the 
phospholipids & the polar functionalities of the 
substrate. 
(2) Nuclear magnetic resonance study of the 
phospholipids complex with some of pure 
precursor indicates that the signals of fatty chain 
are almost unchanged. Such evidences inferred 
that two long aliphatic chains are wrapped around 
the active principle, producing a lipophilic envelop 
that shields the polar head of the phospholipids. 
(3) Phytosome are lipophilic substance with a definite 
melting point, freely soluble in non polar solvents 
& moderately soluble in fats.  
(4) When treated with water, they assume a miceller 
shape, forming structure that resembles liposomes 
exhibiting fundamental differences. 
 
Difference between Phytosome & Liposome
13
: 
(1) In Phytosome active chemical constituents 
molecules are anchored through chemical bonds to 
the polar head of phospholipid. In liposome the 
active principle is dissolved in the medium of the 
cavity or in the layers of membrane. No chemical 
bonds are formed.  
(2) In Phytosome phosphatidylcholine and the 
individual plant compound form 1:1 or 1:2 
complex depending on the substance. In liposome 
hundreds and thousands of phosphatidylcholine 
molecules surrounds the water soluble molecule. 
 
Different form of Phytosome Formulations
14
 
Phytosome complex can be formulated in both oral 
dosage form & topical dosage form. 
Soft gelatin capsule The phytosome complex can be 
dispersed in oily vehicle to obtain suspension to be 
filled in soft gelatin capsule. Vegetable and semi 
synthetic oil can be used. 
Hard gelatin capsule The Phytosome complex can be 
formulated in hard gelatin capsule. 
Tablets The Phytosome complex can be formulated in 
tablet dosages form. 
Topical dosage form The Phytosome complex can be 
formulated topically as well. The ideal process to 
incorporate the phytosome complex in emulsion is to 
disperse the phospholipid complex in a small amount 
of lipid phase and add it to the already created 
emulsion at low temperature the phytosome complexes 
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are dispersible in the solvent employed for topical 
formulation. 
Phytosome In Cosmetic
15 The phytosome have a 
marked lipophilic character and improve topical 
absorption of complex molecules which show 
improved specific activity in the skin function such as 
hydration, collagen structure, enzyme balance etc. 
Topical absorption of biologically active 
phytoconstituents provides local application at the site 
of requirement. The phytosome process intensifies 
herbal compounds by improving absorption increasing 
bioavailability& enhancing delivery to tissue. By 
combining the emulsifying action of the phospholipid 
with the standardized botanical extracts, the phytosome 
form provides dramatically enhanced bioavailability 
and delivers faster & improved absorption through 
skin. 
Therefore application of natural molecule in form of 
phytosome improves its absorption, nourishes the skin 
& act as functional cosmetic. Functional cosmetics are 
topical cosmetic pharmaceutical hybrids intended to 
enhance the beauty through ingredients that provide 
additional health related function or benefits. 
The dual application of phytosome as topical 
pharmaceutical agent & cosmetic with improved 
efficacy & safety results in proper utilization of herbals 
that is too in cost effective manner. 
 
Different Method of Preparation of Phytosomes
7 
Phytosomes are prepared by reacting 2-3 moles of a 
natural or synthetic phospholipid, such as 
phosphatidylcholine, phosphatidylethanolamine or 
phosphatidylserine with one mole of phytoconstituents 
either alone or in the natural mixture in aprotic solvent 
such as dioxane  or acetone in a1:1 or 1:2 ratio . The 
optimum ratio of phospholipid to phytoconstituent is 
1:1. The complex thus formed can be isolated by 
precipitation with an aliphatic hydrocarbon or 
lyophilization or spray drying. 
 Zhi Peng Chen et al reported the method of 
preparation of complex of Ginkgo biloba extract & 
phospholipid. They weighed ginkgo biloba extract & 
phospholipid equivalently and dissolved in anhydrous 
ethanol and then the mixture was magnetically stirred 
for 2 hr. at room temperature. Afterwards ethanol was 
evaporated off under vacuum at 40º C. The dried 
residues were gathered and placed in the desiccator 
overnight16. 
Vinod et al reported the method of preparation of 
Naringenin Phospholipid complex, According to the 
method equimolar concentration of 
Phosphatidylcholine and naringenin were placed in 100 
ml round bottom flask and refluxed in dichloromethane 
for 3 hr. On concentrating the solution to 5-10 ml, 30 
ml of n-hexane was added to get the complex as a 
precipitate followed by filtration.  According to another 
method reported drug (silybin) and phospholipid were 
placed in a100 ml round bottom flask and dissolved in 
anhydrous ethanol. After ethanol was evaporated off 
under vaccum at 40º C the dried residues were gathered 
& placed in desiccators17. 
Shrikant et al reported the mechanical dispersion 
method for preparation of marsupsin-phospholipid 
complex. In this methhhod phospholipid is dissolved in 
a suitable solvent & active ingredient is added drop by 
drop while sonicating the solution .They also reported 
the method of preparation of curcumin phytosome. 
Curcumin phospholipid complexes are prepared by 
adding the phospholipid to the ethanol solution of the 
hydrochloric extract of turmeric rhizome under reflux 
& with stirring. The prepared complex can be isolated 
by precipitation with nonsolvent, lyophilization, spray 
reagent or vaccum drying18. 
Sowjanya et al reported the method of preparation of 
silybin phospholipid complex. According to them 
silybin & phospholipids were resolved into the medium 
after the organic solvent was removed under vaccum 
condition silybin phospholipids complex was formed.2 
Shalini et al reported the solvent evaporation method 
for preparation of phytosome. Phytosome of 
gingsenoside, puerarin & kushenin are prepared by this 
method. Phospholipid is dissolved in a suitable solvent 
& active ingredient is added drop by drop while 
sonicating the solution13.  
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Characterization of Phytosome 
Morphological Studies
 19
: 
 Penetration of the skin barrier is size dependent, and 
nano-sized particles are more likely to enter more 
deeply into the skin than larger ones, hence, particle or 
vesicular size determination is an important aspect in 
designing the formulation for topical application. The 
average diameters of vesicles or particles are mainly 
determined by dynamic light scattering using a 
Zetasizer. The scanning electron microscope another 
important device which play vital role to determined 
the morphological characteristics of vesicular delivery 
systems. It produce images by probing the specimen 
with a focused electron beam that is scanned across a 
rectangular area of the specimen; the produce images 
are good representations of the 3-dimensional shape of 
the sample. It is considered as an important evaluation 
parameter for phytosome preparation.  
 The ability to determine the positions of atoms within 
materials has made the transmission electron 
microscope (TEM), an important tool in the research 
and development of nanotechnologies and vesicular 
drug delivery system. TEM analysis plays a vital role 
in for phytosome preparations.  
Entrapment Efficiency 
20
:  
 Entrapment efficiency is the percentage of the initial 
drug or active constituent incorporated into vesicular 
systems. Entrapment efficiency is can be estimated by 
centrifugation method. The prepared formulations are 
placed in centrifugation tube and centrifuged at 14,000 
rpm for 30 min. The supernatant (1 mL) is withdrawn 
and diluted with phosphate-buffered solution (PBS) 
(pH 7.4) or distilled water. The concentration of 
entrapped phytoconstituent (drug) is then determined 
by UV spectrophotometer at a wavelength at which the 
maximum peak (λ max) is obtained for that constituent. 
% 𝑒𝑛𝑡𝑟𝑎𝑝𝑚𝑒𝑛𝑡 =
𝑡𝑜𝑡𝑎𝑙 𝑑𝑟𝑢𝑔 − 𝑑𝑖𝑓𝑓𝑢𝑠𝑒𝑑 𝑑𝑟𝑢𝑔
𝑇𝑜𝑡𝑎𝑙 𝑑𝑟𝑢𝑔 
× 100 
 
In-Vitro Drug Release
20
: 
Drug release can be observed using the dialysis method 
at room temperature. After reconstituting the freeze-
dried formulation in distilled water/PBS, an aliquot of 
each formulation (0.1 mL) is placed in a dialysis tube 
(molecular weight cutoff dialysis membrane: 12,000-
14,000 Mw,), which is tightly sealed. The tube is 
immersed in 200 mL release medium, PBS (pH 7.4), to 
maintain sink condition and stirred at 300 rpm on a 
magnetic stirrer. Samples (0.5 mL) are taken at 
predetermined time intervals for 24 h, and replenished 
with an equal volume of fresh medium. The 
concentration of drug is determined by HPLC or UV 
after appropriate dilution with acetonitrile without 
further treatment. 
For Topical Formulations in Vitro Sun Protection 
Factor Determination by UV Spectrophotometer
 [19] 
Ratio of UV doses protected to unprotected gives the 
sun protection factor (SPF). The in vitro method 
measures the reduction of the irradiation by measuring 
the transmittance after passing through a film of 
product. The most common in vitro technique involves 
measuring the spectral transmittance at UV 
wavelengths from 280 to 400 nm. The observed 
absorbance values at 5 nm intervals are calculated 
using the following formula: 
𝑆𝑃𝐹𝑠𝑝𝑒𝑐𝑡𝑟𝑜𝑝 𝑕𝑜𝑡𝑜𝑚𝑒𝑡𝑟𝑖𝑐 = 𝐶𝐹 × 𝐸𝐸(𝜆) × 𝐼(𝜆) × 𝐴𝑏𝑠(𝜆)
320
290
 
Where CF = correction factor (10), EE (λ) = 
erythmogenic effect of radiation with wavelength λ, 
Abs (λ) = spectrophotometric absorbance values at 
wavelength λ. The values of EE Χ I are constants. The 
aliquots prepared were scanned between 290 and 320 
nm and the obtained absorbance values were multiplied 
with the respective EE (λ) Χ I (λ) values. Then their 
summation was taken and multiplied with the 
correction factor. 
Transition Temperature
18
:  The transition 
temperature of the vesicular lipid systems can be 
determined by differential scanning calorimetry. 
 
Surface Tension Activity Measurement
21
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The surface tension activity of the drug in aqueous 
solution can be measured by the ring method in a Du 
Nouy ring tensiometer. 
Vesicle Stability
22
 
The stability of vesicles can be determined by 
assessing the size and structure of the vesicles over 
time. The mean size is measured by DLS and structural 
changes are monitored by TEM. 
 
 
Table 2: Some Patented Phytosome Technology
35
  
Title of patent Innovation  Patent No 
Phospholipid complexes of olive 
fruits or leaves extracts having 
improved bioavailability  
Phospholipids complexes of olive fruits or leaves extracts or 
compositions containing it having improved bioavailability. 
EP/1844785  
 
Compositions comprising Ginkgo 
biloba derivatives for the treatment of 
asthmatic and allergic conditions  
Compositions containing fractions deriving from Ginkgo 
biloba, useful for the treatment of asthmatic and allergic 
conditions  
EP1813280  
 
Fatty acid monoesters of sorbityl 
furfural and compositions for 
cosmetic and dermatological use.  
Fatty acid monoesters of sorbityl furfural selected from two 
diff series of compounds in which side chain is a linear or 
branched C3 –C19 alkyl radical optionally containing at 
least one ethylenic unsaturation  
EP1690862  
 
Cosmetic and dermatological 
composition for the treatment of 
aging or photo damaged skin  
Composition for topical treatment of the skin comprises a 
substance that stimulates collagen synthesis and a substance 
that enhances the interaction between extracellular matrix 
and fibroblasts Cosmetic or dermatological composition for 
topical treatment  
EP1640041  
Treatment of skin, and wound repair, 
with thymosin β4 
Compositions and methods for treatment of skin utilizing 
thymosin β4.  
US/2007/ 
015698  
Soluble isoflavone 
compositions  
 
Isoflavone compositions exhibiting improved solubility 
(e.g., light transmittance), taste, color, and texture 
characteristics, and methods for making the same  
WO/2004/ 
045541  
 
An anti-oxidant preparation based on 
plant extracts for the treatment of 
circulation and adiposity problems  
 
Preparation based on plant extracts which has an anti-
oxidant effect and is particularly useful in treatment of 
circulation problems  
such as phlebitis, varicose veins, arteriosclerosis, 
haemorrhoids and high blood pressure 
EP1214084  
 
Complexes of saponin with 
phospholipids and  
pharmaceutical and cosmetic 
compositions containing them 
 Complexes of saponins with natural or synthetic 
phospholipid have high lipophilia and improved 
bioavailability and are suitable for use as active principle in 
pharmaceutical, dermatologic and cosmetic compositions. 
EP0283713 
 
Research Carried Out On Phytosome to Increase 
the Bioavailability: 
 
Recent research shows improved absorption and 
bioavailability with phytosomes as compared to the 
conventional means. Most of the phytosomal studies 
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are focused to Silybum marianum (milk thistle) which 
contains premier liver-protectant flavonoids. 
Yanyu et al. prepared the sily marin phytosome and 
studied its pharmacokinetics in rats. In this study the 
bioavailability of silybin in rats was increased 
remarkably after oral administration of prepared silybin 
phospholipid complex due to an impressive 
improvement of the lipophilic property of Silybin-
phospholipid complex and improvement of the 
biological effect of silybin[23]. 
Tedesco et al. reported silymarin phytosome show 
better antihepatotoxic activity than silymarin alone and 
can provide protection against the toxic effects of 
aflatoxin B1 on performance of broilerchicks. Busby et 
al reported that the use of a silymarin phytosome 
showed a better photoprotectant activity from 
ethanol‐inducedbehavioural deficits than uncomplexed 
silymarin. Grange et al.conducted a series of studies on 
silymarin phytosome, containing a standardized extract 
from the seeds of S. marianum, administered orally and 
found that it could protect the fetus from maternally 
ingested ethanol[24]. 
Bombardelli et al. reported Silymarin phytosomes, in 
which silymarin (a standardized mixture of 
flavanolignans extracted from the fruits of S. 
marianum) was complexes with 
phospholipids.Phytosomes showed much higher 
specific activity and a longer lasting action than the 
single constituents, with respect to percent reduction of 
edema, inhibition of myeloperoxidase activity, 
antioxidant and free radical scavenging properties [25]. 
Zhi-peng Chen et al studied the improvement of oral 
bioavailability of Ginkgo biloba extract (GBE) through 
preparing G. biloba extract phospholipid complexes 
(GBP) and G. biloba extract solid dispersions (GBS). 
Firstly they prepared the GBP and GBS and studied 
their physicochemical properties by differential 
scanning calorimetry (DSC), powder X-ray diffraction 
(XRD) and dissolution. Then they studied the 
pharmacokinetic characteristics and bioavailability in 
rats. The results showed that the bioavailability of 
quercetin, kaempferol and isorhamnetin in rats was 
increased remarkably after oral administration of GBP 
and GBS comparing with GBE. The bioavailabilities of 
GBP increased more than that of GBS[16]. 
Comoglio et al studied that ethanol metabolism by 
cytochrome P4502El (CYP2El) produces free radical 
intermediates, identified as hydroxyl ethyl radicals. 
They observed that in vitro addition or in vivo 
pretreatment of rats with Silipide. A new l:l complex of 
silybin with phosphatidyl-choline, was able to decrease 
the spin trapping of hydroxyl ethyl radicals in 
microsomes from chronic alcohol-fed rats[26].  
Suresh et al studied the protective effects of 
Ginkgoselect Phytosome (GBP) on Rifampicin (RMP) 
induced hepatotoxicity and the probable mechanism 
involved in this protection was investigated in rats.  
They studied that flavonoids of Ginkgo biloba easily 
absorbed when administered in the form of Ginkgo 
select Phytosome [27]. 
Jia et al studied the potential of nanostructured lipid 
carriers (NLCs) for the intravenous delivery of silybin, 
a poorly water-soluble antihepatopathy agent.  In vitro 
release test, silybin-NLC exhibited a biphasic drug 
release pattern with burst release at the initial stage and 
sustained release afterwards. Compared with silybin 
solution, silybin-NLC showed higher AUC values and 
prolonged residence time of drug in the blood 
circulation [28]. 
Yan Lu et al prepared a new formulation of 
clarithromycin emulsion (ClaE) with the 
clarithromycin–phospholipid complex which was 
analyzed by DSC. The results showed that ClaE has 
enough physicochemical stability to undergo 
sterilization and storage. The pharmacokinetic study 
showed that both ClaE and ClaS fitted a three-
compartment model, their pharmacokinetic curves 
were similar and the main parameters showed no 
significant difference except Vss. ClaE has a great 
potential for clinical applications and industrial-scale 
production [29].  
Giovanni B et al evaluate the effect of a standardized 
formulation of a polyphenolic extract of grapes 
(Leucoselect-Phytosome [LP]) on low-density 
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lipoprotein (LDL) susceptibility to oxidation in a group 
of heavy smokers. Compliance was good, and no 
adverse effects were recorded. Subjects did not show 
significant modification of total cholesterol (TC), 
triglycerides (TG), high-density lipoprotein-cholesterol 
(HDL-C) and LDL-C during LP treatment. The 
antioxidant potential of grape seed extract polyphenols 
may prove effective in a model of oxidative stress[30]. 
Ramadan et al developed a novel phenolipids 
formulation containing a complex of quercetin and soy 
lecithin. Antioxidant and antiradical characteristics of 
native soy lecithin and phenolipids’ formulations (com-
plexes of quercetin and lecithin, 1:99 and 3:97, w/w) in 
the protection of triolein and sunflower oil (SFO) 
models stored under accelerated oxidative conditions 
for 15 day at 60˚C were studied. Progress of oxidation 
was monitored by recording the ultraviolet absorptivity 
and measuring the formation of oxidative products 
(peroxide value). The antiradical action of different 
lipid matrices against DPPH· and galvinoxyl radicals 
was screened during Shaal oven test[31].  
 Parsaea et al prepared and  studied the topical 
performance of some new lipid-based formulations of 
diclofenac, diclofenac aqueous gel containing mixed 
micelles (sodium cholate:egg lecithin molar ratio 0.55) 
diclofenac lotion that contains soya lecithin, ethanol 
and buffer and  diclofenac lipogel containing egg 
lecithin, isopropyl myristate, propylene glycol and 
ethanol. Drug release profile and diffusion coefficients 
were compared with brand formulation. The results 
showed that diclofenac lotion and lipogel maybe more 
suitable formulations than the conventional topical 
dosage form [32].  
 Semalty et al studied that poor and/or erratic oral 
bioavailability of polyphenolics can be improved using 
the Phytosome delivery system, a strategy that 
enhances the rate and the extent of solubilization into 
aqueous intestinal fluids and the capacity to cross 
biomembranes. Phospholipids show affinity for 
polyphenolics and form supramolecular adducts having 
a definite stoichiometry. They studied the preparation 
and characterization of Phytosome complexes and their 
activity in various medicinal (cardiovascular, anti-
inflammatory, hepatoprotective, anticancer) and 
cosmetic (skin aging) realms of application[33]. 
 Kashaw et al studied that liver an imperative organ has 
a crucial in the metabolism of xenobiotics that causes it 
to succumb to numerous hepatic diseases. Synthetic 
drugs exploited in the treatment of liver diseases are 
incompetent and may sometimes lead to serious side-
effects. Many herbs have been proven to be effectual as 
hepatoprotective agents while many more are claimed 
to be hepatoprotective but lack any such scientific 
evidence to support such claims. Developing a 
satisfactory herbal therapy to treat severe liver diseases 
requires systematic investigation of properties such as 
antiviral action (Hepatitis B, Hepatitis C), anti-
hepatotoxicity (antioxidants), and stimulation of liver 
cell regeneration activity. They reviews the scope of 
herbal plants as well as novel delivery systems like 
liposomes and phytosomes for the treatment of 
hepatotoxicity and liver related disorders [34]. 
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